2.Cytomorphic Effects of Chemical and Hormonal Agents, and Electronic Stimulation on the Peritoneal Mast Cells of the Rat.
Yung Keun OH ; Kum Duck CHOI ; Hyuck BANG ; Man Soo PAK
Yonsei Medical Journal 1968;9(1):52-58
After the intraperitoneal injections of alloxan, carbon tetrachloride, cortisone acetate, adrenocorticotrophic hormone, morphine hydrochloride, toluidin blue, physiological saline solution, distilled water, and direct stimulation with electronic current, the peritoneal mast cells of the rat were observed in order to document and study the cytomorphic changes. Adult Sprague-Dawley strain albion rats were used. The substances tested were dissolved in physiological saline solution and injected into the abdominal cavity. Three to twenty four hours later the rats were sacrificed and the morphological changes of the peritoneal mast cells were observed by means of phase contrast microscopy and ordinary light microscopy. Cytomorphic effects of alloxan on the mast cells were comparatively marked and those effects of CC14, cortisone, ACTH, morphine-HCI, and physiological saline solution were slight and similar to each other. But the distructive effects of toluidin blue, distilled water, and electronic stimulation on the mast cells were severe and noticeable in this study. These results indicate that the intraperitmeal mast cells of rats show more sensitive reactions to a metabolic poisn alloxan, a low osmotic pressured-material distilled water, and a histamine liberator toluidin blue, and a physical stimulus electronic stimulation than the other similar chemical agents.
Animal
;
Electric Stimulation*
;
Hormones/pharmacology*
;
Mast Cells/cytology*
;
Mast Cells/drug effects*
;
Rats
3.Targeted therapies for hormone-refractory prostate cancer.
National Journal of Andrology 2010;16(12):1108-1112
Prostate cancer is one of the most common type of cancer among men after middle age. Androgen withdrawal can delay its progression in the initial stage, but it finally becomes independent of androgens in almost all the cases. The combination of docetaxel with prednisone is currently a standard first-line treatment for patients with hormone-refractory prostate cancer (HRPC), but hitherto there is no established second-line therapy. In view of the molecular pathogenesis of HRPC, this article presents an overview on several promising drugs that target specific pathways, involving angiogenesis, cell signaling, apoptosis and proliferation, and immune modulation, either as single agents or in combination with cytotoxic chemotherapy.
Drug Resistance, Neoplasm
;
Hormones
;
pharmacology
;
Humans
;
Male
;
Prostatic Neoplasms
;
drug therapy
4.Steroid-resistant nephrotic syndrome and NPHS1 gene.
Chinese Journal of Pediatrics 2011;49(11):862-865
6.Contributions of flavonoids from citri reticulatae pericarpium to gastric hormones, CD3~+ and TFF3 mRNA expression in rats with spleen deficiency intervened by Liujunzi Decoction.
Shao-Wa LYU ; Ying LI ; Xin YU ; Yu-Yan GUO ; Da-Yu YANG ; Shuang SUN ; Er-Yu SHANG
China Journal of Chinese Materia Medica 2022;47(4):951-958
The present study established the spectrum-effect relationship model of flavonoids in Citri Reticulatae Pericarpium(CRP) from 15 batches of Liujunzi Decoction and statistically analyzed the correlation between chemical peaks and efficacy to identify the main effective components. HPLC fingerprints of flavonoids in CRP from 15 batches of Liujunzi Decoction were established. HPLC analysis was carried out on the Venusil XBP C_(18)(L) column(4.6 mm×250 mm, 5 μm) at 30 ℃ with acetonitrile-water(containing 0.1% formic acid) as mobile phase for gradient elution, a flow rate of 1.0 mL·min~(-1), and detection wavelength of 300 nm to obtain chemical fingerprints. Additionally, the effects of flavonoids from CRP in 15 batches of Liujunzi Decoction on the content of GAS, MTL, and VIP, TFF3 mRNA expression, and percentage of CD3~+ T-cells of model rats with spleen deficiency were determined. The spectrum-effect relationship model was established by gray correlation analysis. The results showed that the main characteristic peaks with great contribution to the regulation of gastrointestinal tract were peak 16(vicenin-2), peak 63(sinensetin), peak 64(isosinensetin), peak 65(nobiletin), peak 67(3,5,6,7,8,3',4'-heptemthoxyflavone), peak 68(tangeretin), and peak 69(5-desmethylnobiletin). Therefore, there was a linear correlation between flavonoids from CRP in Liujunzi Decoction and the efficacy, and the medicinal effect was achieved by multi-component action. This study is expected to provide a new idea for exploring the material basis of the effect, i.e., regulating qi prior to replenishing qi, of CRP in Liujunzi Decoction.
Animals
;
Citrus/chemistry*
;
Drugs, Chinese Herbal
;
Flavonoids/pharmacology*
;
Hormones
;
RNA, Messenger/genetics*
;
Rats
;
Spleen
7.Research of cellular toxic effect to Hep-2 of recombinant toxin MSH-Ang.
Weiguo ZHOU ; Xin NI ; Zhigang HUANG ; Jugao FANG ; Demin HAN ; Dongdong ZHU ; Zhen DONG ; Zhanquan YANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2009;23(5):225-226
OBJECTIVE:
To study the cytotoxicity of recombinate toxin MSH-Ang to Hep-2.
METHOD:
The depurated MSH-Ang were applied in cytotoxicity experiment, and the growth inhibiting action to laryngeal carcinoma cell Hep-2 were observed.
RESULT:
Recombination protein inhibited the growth of laryngeal carcinoma cell Hep-2, and its inhibiting action enhanced and corpuscular mortality rate increased along with the concentration increasing.
CONCLUSION
Recombinant toxin MSH-Ang can not only take special effect in tumors with high MSHR, but also target to many other popular tumors.
Angiopoietins
;
genetics
;
pharmacology
;
Cell Line, Tumor
;
Genetic Engineering
;
Humans
;
Laryngeal Neoplasms
;
Melanocyte-Stimulating Hormones
;
genetics
;
pharmacology
;
Recombination, Genetic
8.Exogenous cysteamine increases basal pancreatic exocrine secretion in the rat.
Hong Sik LEE ; Kwang Hee KIM ; Chang Duck KIM ; Chi Wook SONG ; Ho Sang RYU ; Jin Hai HYUN
Journal of Korean Medical Science 1999;14(1):52-56
To determine whether exocrine pancreatic secretion is regulated by endogenous somatostatin, somatostatin deficiency was induced by cysteamine. Rats were subcutaneously administered a single dose of cysteamine (30 mg/100 g body weight) 12 hr before experiment. Anesthetized rats were prepared with cannulation into bile duct, pancreatic duct, duodenum, and jugular vein and pancreatic juice was collected. For in vitro study, isolated pancreata of rats, pretreated with cysteamine, were perfused with an intraarterial infusion of Krebs-Henseleit solution (37 degrees C) at 1.2 mL/min, and pancreatic juice was collected in 15-min samples. In vivo experiment of the rat, the mean basal pancreatic secretions, including volume, bicarbonate, and protein output were significantly increased from 18.4+/-0.5 microL/30 min, 0.58+/-0.05 microEq/30 min, and 214.0+/-26.1 microg/30 min to 51.6+/-3.7 microL/30 min, 1.52+/-0.11 microEq/30 min, and 569.8+/-128.9 microg/30 min, respectively (p<0.05). In the isolated perfused pancreas, cysteamine also resulted in a significant increase in basal pancreatic secretion (p<0.05). Simultaneous intraarterial infusion of octreotide (10 pmol/hr) to isolated pancreata partially reversed the effect of cysteamine on basal pancreatic secretion. These findings suggest that endogenous somatostatin play an important role on the regulation of basal pancreatic exocrine secretion.
Animal
;
Cysteamine/pharmacology*
;
Hormone Antagonists/pharmacology*
;
Hormones, Synthetic/pharmacology
;
In Vitro
;
Male
;
Octreotide/pharmacology
;
Pancreas/secretion
;
Pancreas/drug effects*
;
Perfusion
;
Rats
;
Rats, Sprague-Dawley
;
Somatostatin/antagonists & inhibitors*
9.Intermittent parathyroid hormone treatment can promote linear growth in the ovariectomized growing rat.
Sung Kil LIM ; Young Jun WON ; Du Hong PARK ; Dong Hwan SHIN ; Jong In YOOK ; Hyun Chul LEE ; Kap Bum HUH
Yonsei Medical Journal 1999;40(2):166-172
To compare the effect of intermittent parathyroid hormone (PTH) treatment with that of estrogen treatment on epiphyseal growth in ovariectomized rats, 46 Sprague-Dawley female rats aged 9-10 weeks (about 200-220 g) were either ovariectomized or sham operated. From 6 weeks after ovariectomy (ovx), rats were daily injected with subcutaneous human recombinant PTH (1-84)-dosed 30 micrograms/kg (the low dose PTH-treated group) or 300 micrograms/kg (the high dose PTH-treated group), 17 beta-estradiol (the 17 beta-estradiol-treated group, 30 micrograms/kg) or vehicle (the ovx-alone group), 5 times a week for 4 weeks. The decalcified sections of the distal femoral epiphyseal plate were analyzed on light microscopy after H&E stain, and the lengths of the zones of proliferation, maturing and hypertrophic chondrocytes were measured. The length of the growth plate, the zone of proliferation and the zone of hypertrophic chondrocyte in the ovx-alone group were significantly shorter than those of the sham-operated group. The treatment of 17 beta-estradiol speeded up the differentiation of cells from proliferating chondrocytes to maturing and hypertrophic chondrocytes even though the length of the growth plate was comparable to that of the sham-operated group. Both low and high dose PTH treatments increased the length of the growth plate, and those lengths were comparable to that of the sham-operated group. The fractions of proliferating, maturing and hypertrophic zone in the low dose PTH-treated group were also comparable to those of the sham-operated group. However, high dose PTH treatment slowed down the differentiation of cells from proliferating chondrocytes to maturing and hypertrophic chondrocytes to a greater extent, and therefore the fraction of proliferating chondrocytes of the high dose PTH-treated group was larger than that of the low dose PTH-treated group (73.8 +/- 1.8 Vs 63.3 +/- 1.3%, p < 0.005). From these results, we showed that intermittent PTH treatment could promote linear growth in the ovariectomized growing rat. We propose that PTH may be an alternative drug candidate for promoting linear growth of long bones without the risk for early closure of the growth plate.
Animal
;
Bone Development/drug effects*
;
Female
;
Human
;
Ovariectomy*
;
Parathyroid Hormones/pharmacology
;
Parathyroid Hormones/administration & dosage*
;
Rats
;
Rats, Sprague-Dawley
;
Recombinant Proteins
10.Small Airways Dysfunction in Asthma: Evaluation and Management to Improve Asthma Control.
Allergy, Asthma & Immunology Research 2014;6(5):376-388
The small airways have been neglected for many years, but interest in the topic has been rekindled with recent advances in measurement techniques to assess this region and also the ability to deliver therapeutics to the distal airways. Current levels of disease control in asthmatic patients remain poor and there are several contributory factors including; poor treatment compliance, heterogeneity of asthma phenotypes and associated comorbidities. However, the proposition that we may not be targeting all the inflammation that is present throughout the whole respiratory tree may also be an important factor. Indeed decades ago, pathologists and physiologists clearly identified the importance of small airways dysfunction in asthmatic patients. With improved inhaler technology to deliver drug to target the whole respiratory tree and more sensitive measures to assess the distal airways, we should certainly give greater consideration to treating the small airway region when seeing our asthmatic patients in clinic. The aim of this review is to address the relevance of small airways dysfunction in the daily clinical management of patients with asthma. In particular the role of small particle aerosols in the management of patients with asthma will be explored.
Adrenal Cortex Hormones
;
Aerosols
;
Asthma*
;
Comorbidity
;
Compliance
;
Humans
;
Inflammation
;
Inhalation
;
Nebulizers and Vaporizers
;
Pharmacology
;
Phenotype
;
Physiology
;
Population Characteristics